|
US20080102121A1
(en)
*
|
1998-11-02 |
2008-05-01 |
Elan Pharma International Limited |
Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone
|
|
US6428814B1
(en)
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
|
US7276249B2
(en)
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
|
US7198795B2
(en)
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
|
US7998507B2
(en)
|
2000-09-21 |
2011-08-16 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
|
|
WO2002045691A2
(en)
*
|
2000-12-06 |
2002-06-13 |
Pharmacia Corporation |
Laboratory scale milling process
|
|
US6976647B2
(en)
|
2001-06-05 |
2005-12-20 |
Elan Pharma International, Limited |
System and method for milling materials
|
|
ATE401959T1
(de)
*
|
2001-06-05 |
2008-08-15 |
Elan Pharma Int Ltd |
Mahlvorrichtung und verfahren zu deren betrieb
|
|
US7758890B2
(en)
*
|
2001-06-23 |
2010-07-20 |
Lyotropic Therapeutics, Inc. |
Treatment using dantrolene
|
|
DE10141650C1
(de)
|
2001-08-24 |
2002-11-28 |
Lohmann Therapie Syst Lts |
Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
|
|
EP1443912B1
(de)
|
2001-10-12 |
2007-08-29 |
Elan Pharma International Limited |
Zusammensetzungen mit einer kombination aus eigenschaften sofortiger freisetzung und kontrollierter freisetzung
|
|
JP4598399B2
(ja)
|
2002-02-04 |
2010-12-15 |
エラン ファーマ インターナショナル,リミティド |
表面安定剤としてリゾチームを有するナノ粒子組成物
|
|
US9101540B2
(en)
|
2002-04-12 |
2015-08-11 |
Alkermes Pharma Ireland Limited |
Nanoparticulate megestrol formulations
|
|
US7101576B2
(en)
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
|
WO2003103632A1
(en)
|
2002-06-10 |
2003-12-18 |
Elan Pharma International, Ltd. |
Nanoparticulate polycosanol formulations and novel polycosanol combinations
|
|
ES2355723T3
(es)
|
2002-09-11 |
2011-03-30 |
Elan Pharma International Limited |
Composiciones de agente activo en nanopartículas estabilizadas en gel.
|
|
CA2513064C
(en)
|
2003-01-31 |
2009-11-10 |
Elan Pharma International, Ltd. |
Nanoparticulate topiramate formulations
|
|
US8512727B2
(en)
|
2003-03-03 |
2013-08-20 |
Alkermes Pharma Ireland Limited |
Nanoparticulate meloxicam formulations
|
|
US20100297252A1
(en)
|
2003-03-03 |
2010-11-25 |
Elan Pharma International Ltd. |
Nanoparticulate meloxicam formulations
|
|
US7140567B1
(en)
*
|
2003-03-11 |
2006-11-28 |
Primet Precision Materials, Inc. |
Multi-carbide material manufacture and use as grinding media
|
|
CA2523035C
(en)
|
2003-05-22 |
2011-04-26 |
Elan Pharma International Ltd. |
Sterilization of dispersions of nanoparticulate active agents with gamma radiation
|
|
ES2318330T3
(es)
*
|
2003-08-08 |
2009-05-01 |
Elan Pharma International Limited |
Nuevas composiciones de metaxalona.
|
|
CA2544627A1
(en)
|
2003-11-05 |
2005-05-19 |
Elan Pharma International Ltd. |
Nanoparticulate compositions having a peptide as a surface stabilizer
|
|
US7000850B2
(en)
*
|
2004-04-27 |
2006-02-21 |
Brand New Technology Ltd. |
Anti-scald water valve assembly
|
|
US7910577B2
(en)
|
2004-11-16 |
2011-03-22 |
Elan Pharma International Limited |
Injectable nanoparticulate olanzapine formulations
|
|
UA89513C2
(uk)
*
|
2004-12-03 |
2010-02-10 |
Элан Фарма Интернешнл Лтд. |
Стабільна композиція з наночастинок ралоксифену гідрохлориду
|
|
SG161203A1
(en)
*
|
2004-12-15 |
2010-05-27 |
Elan Pharma Int Ltd |
Nanoparticulate tacrolimus formulations
|
|
US20060159767A1
(en)
*
|
2004-12-22 |
2006-07-20 |
Elan Pharma International Limited |
Nanoparticulate bicalutamide formulations
|
|
CA2594332A1
(en)
*
|
2005-01-06 |
2006-07-13 |
Elan Pharma International Ltd. |
Nanoparticulate candesartan formulations
|
|
EA013433B1
(ru)
*
|
2005-02-15 |
2010-04-30 |
Элан Фарма Интернэшнл Лтд. |
Аэрозольные и впрыскиваемые рецептуры лекарственных препаратов бензодиазепина, состоящего из наночастиц
|
|
US20080254114A1
(en)
*
|
2005-03-03 |
2008-10-16 |
Elan Corporation Plc |
Controlled Release Compositions Comprising Heterocyclic Amide Derivative Nanoparticles
|
|
US20060204588A1
(en)
*
|
2005-03-10 |
2006-09-14 |
Elan Pharma International Limited |
Formulations of a nanoparticulate finasteride, dutasteride or tamsulosin hydrochloride, and mixtures thereof
|
|
US20070065374A1
(en)
*
|
2005-03-16 |
2007-03-22 |
Elan Pharma International Limited |
Nanoparticulate leukotriene receptor antagonist/corticosteroid formulations
|
|
EA200701997A1
(ru)
*
|
2005-03-17 |
2008-02-28 |
Элан Фарма Интернэшнл Лтд. |
Композиция из наночастиц бисфосфоната
|
|
AU2006226887A1
(en)
|
2005-03-23 |
2006-09-28 |
Elan Pharma International Limited |
Nanoparticulate corticosteroid and antihistamine formulations
|
|
BRPI0607537A2
(pt)
*
|
2005-04-12 |
2009-09-15 |
Elan Pharma Int Ltd |
formulações de derivado de quinazolina nanoparticulado
|
|
EP1888037A2
(de)
*
|
2005-05-10 |
2008-02-20 |
Elan Pharma International Limited |
Clopidogrel-nanopartikelformulierungen
|
|
US20110064803A1
(en)
*
|
2005-05-10 |
2011-03-17 |
Elan Pharma International Limited. |
Nanoparticulate and controlled release compositions comprising vitamin k2
|
|
US20100028439A1
(en)
*
|
2005-05-23 |
2010-02-04 |
Elan Pharma International Limited |
Nanoparticulate stabilized anti-hypertensive compositions
|
|
US20060292214A1
(en)
*
|
2005-06-03 |
2006-12-28 |
Elan Pharma International Limited |
Nanoparticulate acetaminophen formulations
|
|
CN101232870A
(zh)
*
|
2005-06-03 |
2008-07-30 |
伊兰制药国际有限公司 |
纳米微粒甲磺酸伊马替尼制剂
|
|
WO2006133045A1
(en)
*
|
2005-06-03 |
2006-12-14 |
Elan Pharma International, Limited |
Nanoparticulate benidipine compositions
|
|
EP1954253A4
(de)
|
2005-06-08 |
2011-07-27 |
Elan Pharma Int Ltd |
Nanoteilchenförmige und kontrolliert freigesetzte zusammensetzungen mit cefditoren
|
|
EP1898882B1
(de)
*
|
2005-06-09 |
2009-10-28 |
Elan Pharma International Limited |
Nanopartikuläre ebastinformulierungen
|
|
CN101237868A
(zh)
*
|
2005-06-13 |
2008-08-06 |
伊兰制药国际有限公司 |
纳米粒氯吡格雷和阿司匹林组合制剂
|
|
JP2008543862A
(ja)
*
|
2005-06-15 |
2008-12-04 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子アゼルニジピン製剤
|
|
CA2614412A1
(en)
*
|
2005-07-07 |
2007-01-18 |
Elan Pharma International, Limited |
Nanoparticulate clarithromycin formulations
|
|
WO2007033239A2
(en)
*
|
2005-09-13 |
2007-03-22 |
Elan Pharma International, Limited |
Nanoparticulate tadalafil formulations
|
|
EP1933814A2
(de)
|
2005-09-15 |
2008-06-25 |
Elan Pharma International Limited |
Nanoteilchenförmige aripiprazol-formulierungen
|
|
CN103265495B
(zh)
|
2005-12-29 |
2016-11-16 |
莱西肯医药有限公司 |
多环氨基酸衍生物及其使用方法
|
|
US7649098B2
(en)
|
2006-02-24 |
2010-01-19 |
Lexicon Pharmaceuticals, Inc. |
Imidazole-based compounds, compositions comprising them and methods of their use
|
|
US8367112B2
(en)
*
|
2006-02-28 |
2013-02-05 |
Alkermes Pharma Ireland Limited |
Nanoparticulate carverdilol formulations
|
|
NZ545960A
(en)
|
2006-03-15 |
2008-04-30 |
Environmental Decontamination |
Milling apparatus
|
|
MX2008015275A
(es)
*
|
2006-05-30 |
2009-02-06 |
Elan Pharma Int Ltd |
Formulaciones de posaconazol en nanoparticulas.
|
|
US20080213374A1
(en)
*
|
2006-07-10 |
2008-09-04 |
Elan Pharma International Limited |
Nanoparticulate sorafenib formulations
|
|
MX2009000391A
(es)
*
|
2006-07-12 |
2009-06-30 |
Elan Pharma Int Ltd |
Formulación de modafinilo en forma de nano-partículas.
|
|
EP2813144A1
(de)
|
2006-10-09 |
2014-12-17 |
Charleston Laboratories, Inc. |
Analgetische Zusammensetzungen enthaltend ein Antihistamin
|
|
UA99270C2
(en)
|
2006-12-12 |
2012-08-10 |
Лексикон Фармасьютикалз, Инк. |
4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
|
|
CA2939778C
(en)
|
2007-01-31 |
2019-01-29 |
Dana-Farber Cancer Institute, Inc. |
Stabilized p53 peptides and uses thereof
|
|
CA2682174C
(en)
|
2007-03-28 |
2021-04-06 |
President And Fellows Of Harvard College |
Stitched polypeptides
|
|
US7748655B2
(en)
*
|
2007-06-15 |
2010-07-06 |
Riley Power, Inc. |
Crusher block assembly for particulate size reduction system
|
|
EP3090743A1
(de)
|
2008-01-09 |
2016-11-09 |
Charleston Laboratories, Inc. |
Pharmazeutische zusammensetzungen
|
|
US20090197780A1
(en)
*
|
2008-02-01 |
2009-08-06 |
Weaver Jimmie D |
Ultrafine Grinding of Soft Materials
|
|
JP2011520779A
(ja)
*
|
2008-03-21 |
2011-07-21 |
エラン・ファルマ・インターナショナル・リミテッド |
イマチニブの部位特異的送達のための組成物および使用の方法
|
|
CA132115S
(en)
*
|
2009-04-03 |
2011-03-10 |
Satake Eng Co Ltd |
Milling screening machine
|
|
CA2763456C
(en)
|
2009-05-27 |
2017-10-24 |
Alkermes Pharma Ireland Limited |
Reduction of flake-like aggregation in nanoparticulate active agent compositions
|
|
CA2767576C
(en)
|
2009-07-08 |
2020-03-10 |
Charleston Laboratories Inc. |
Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
|
|
US20120316171A1
(en)
|
2009-11-05 |
2012-12-13 |
Tamas Oravecz |
Tryptophan Hydroxylase Inhibitors for the Treatment of Cancer
|
|
EP2533778A1
(de)
|
2010-02-10 |
2012-12-19 |
Lexicon Pharmaceuticals, Inc. |
Tryptophanhydroxylasehemmer zur behandlung von knochenmetastasen
|
|
WO2011146583A2
(en)
|
2010-05-19 |
2011-11-24 |
Elan Pharma International Limited |
Nanoparticulate cinacalcet formulations
|
|
KR20130099938A
(ko)
|
2010-08-13 |
2013-09-06 |
에일러론 테라퓨틱스 인코포레이티드 |
펩티도미메틱 거대고리
|
|
CN104039342A
(zh)
|
2011-10-18 |
2014-09-10 |
爱勒让治疗公司 |
拟肽大环化合物
|
|
HK1205454A1
(en)
|
2012-02-15 |
2015-12-18 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
|
NZ627528A
(en)
|
2012-02-15 |
2016-05-27 |
Aileron Therapeutics Inc |
Peptidomimetic macrocycles
|
|
US20130303763A1
(en)
|
2012-03-30 |
2013-11-14 |
Michael D. Gershon |
Methods and compositions for the treatment of necrotizing enterocolitis
|
|
SG11201503052RA
(en)
|
2012-11-01 |
2015-05-28 |
Aileron Therapeutics Inc |
Disubstituted amino acids and methods of preparation and use thereof
|
|
WO2015071841A1
(en)
|
2013-11-12 |
2015-05-21 |
Druggability Technologies Holdings Limited |
Complexes of dabigatran and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them
|
|
CA2949236C
(en)
|
2014-05-15 |
2023-06-13 |
Incube Labs, Llc |
Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins
|
|
MX2017003797A
(es)
|
2014-09-24 |
2017-06-15 |
Aileron Therapeutics Inc |
Macrociclos peptidomimeticos y usos de los mismos.
|
|
WO2016154058A1
(en)
|
2015-03-20 |
2016-09-29 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
|
CN105381843B
(zh)
*
|
2015-11-25 |
2017-08-15 |
河北新四达电机股份有限公司 |
低速大转矩永磁电机直驱式球磨机系统
|
|
EP3423041A4
(de)
|
2016-03-04 |
2019-09-11 |
Charleston Laboratories, Inc. |
Pharmazeutische zusammensetzungen
|
|
US10881135B1
(en)
|
2017-11-10 |
2021-01-05 |
Creative Destruction, LLC |
Cyclonically cooled and filtered smoking water pipe and method
|
|
CN109012906A
(zh)
*
|
2018-07-10 |
2018-12-18 |
黄玉发 |
一种建筑垃圾碾压式破碎装置
|
|
AU2023228095A1
(en)
|
2022-03-02 |
2024-08-15 |
Horizon Therapeutics Ireland Dac |
Process of making a crystalline edg-2 receptor antagonist
|